Category: Stock Market

  • Telix (ASX:TLX) share price slips despite priority review status

    medical research

    The Telix Pharmaceuticals Ltd (ASX: TLX) share price is slipping today, down 2.5% in afternoon trading.

    This comes despite the company reporting it had received priority review status from Australia’s Therapeutic Goods Administration (TGA) for its prostate cancer imaging product, TLX591-CDx.

    The priority review provides Telix with a fast-tracked timeframe of 150 working days for its product dossier review and approval.

    It’s possible this news was already factored into the share price. Telix shares soared 121% higher in the month of November, and the share price is up 152% year-to-date. By comparison, the S&P/ASX 200 Index (ASX: XJO) is flat since 2 January.

    What does Telix Pharmaceuticals do?

    Telix Pharmaceuticals is a biopharmaceutical company focused on developing diagnostic and therapeutic products via molecularly targeted radiation (MTR). Based in Melbourne, Telix has international operations in Belgium, Japan and the United States.

    The company is currently developing a range of clinical-stage oncology products to address unmet medical needs involving prostate, kidney and brain cancers.

    What does the priority review status mean for Telix shares?

    Addressing the priority review status, Telix CEO Chris Behrenbruch said:

    As an Australian headquartered company, we are especially delighted that the TGA has granted Priority Review for TLX591-CDx, bringing us one step closer to providing a commercially available prostate imaging agent to patients in our own backyard.

    This is an important development for urologic oncology in Australia as a properly validated and commercially available product will ensure far greater patient access and confidence in the technology, currently only available on a limited basis under “special access” use from a relatively small number of academic nuclear medicine departments around the country.

    The company reported that its Medical Services Advisory Committee (MSAC) application is already in progress. In a forward-looking statement, it revealed that it expects that MSAC approval and commercial availability of TLX591-CDx around May or June of 2021, provided it receives the TGA approval.

    With prostate cancer killing 3,000 Aussie men each year (the second most common cause of cancer death), there are good reasons to hope Telix’s imaging product is successful beyond any share price gains.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Telix (ASX:TLX) share price slips despite priority review status appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3gion8U

  • Regional Express (ASX:REX) share price soars to 13-year high

    rising airline asx share price represented by boy playing with toy plane

    The Regional Express Holdings Ltd (ASX: REX) continued on its vertical ascend today with the stock hitting a 13-year high.

    The REX share price surged another 27.3% to $2.47 during lunch time trade when the S&P/ASX 200 Index (Index:^AXJO) inched up 0.3%.

    In contrast, the Qantas Airways Limited (ASX: QAN) share price jumped 3.1% to $5.44 and Alliance Aviation Services Ltd (ASX: AQZ) share price fell 2.1% to $3.82 at the time of writing.  

    Regional Express share price gets speeding ticket

    A number of positive tailwinds have pushed the Regional Express share price higher recently, including hopes of a COVID‐19 vaccine.

    But today’s big rise seems to have also baffled the airline after it was issued with a speeding ticket by ASX Ltd (ASX:ASX).

    Management offered a number of possible reasons for REX’s soaring share price.

    Rising confidence in REX share price

    The successful airfare promotion of $69 for a one-way trip between Melbourne and Sydney is one explanation. This could have lifted REX’s profile among the public and investors.

    Confidence in REX’s ability to transition to flying jets from propeller aircraft and launch a domestic service between major cities is touted as another potential driver for its share price.

    “The recognition by investors of Rex’s attractive lower cost structure relative to its competitors, including because, as reported recently in the press, Virgin has been unsuccessful in lowering its wage structure after negotiations with unions,” said REX.

    “The more positive general sentiment in the aviation sector due to the re-opening of domestic borders which has increased demand for passenger services with all airlines.”

    Finally, management acknowledged that day traders may also be contributing to the heightened volatility in the stock.

    How the REX share price is performing to the sector

    Regardless, REX’s shareholders are unlikely to be complaining as the Regional Express share price nearly doubled since the start of 2020.

    Not even the popular Qantas share price could keep up as the flying kangaroo crashed by more than 20% over the same period. The Sydney Airport Holdings Pty Ltd (ASX: SYD) share price is also down by a similar amount.

    The AQZ share price is doing better, but even than its 51% rise this year can’t keep pace with the REX share price.

    But Regional Express isn’t the only stock that looks well placed for 2021. The experts at the Motley Fool are bullish on the outlook of these other ASX stocks.

    Follow the link below to find out more.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Regional Express (ASX:REX) share price soars to 13-year high appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/37JUGJQ

  • CSL (ASX:CSL) share price on watch after hints of ‘far more robust’ vaccine

    vials of medication labelled with COVID-19 vaccine stickers

    The CSL Limited (ASX: CSL) share price is edging higher today, up 0.2% in afternoon trading.

    That’s broadly in line with the wider S&P/ASX 200 Index (ASX: XJO), up 0.4% at time of writing.

    With a history of generally delivering fairly steady share price growth, 2020 has been unusually volatile for CSL shareholders. While there are various reasons for this, traders jumping in and out of shares based on the latest COVID-19 vaccine news have certainly helped stir this year’s share price volatility.

    CSL and the University of Queensland (UQ) have been working collaboratively on a coronavirus vaccine since the outset of the pandemic.

    The sprint to the finish line looks to have been won by the mRNA vaccines developed by Moderna Inc (NASDAQ: MRNA), along with the partnered efforts of Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX).

    But the experts at CSL and the UQ believe their own efforts may prove more valuable in the long run.

    More on that below. But first…

    What does CSL do?

    CSL is a global biotechnology company that develops and delivers innovative biotherapies and influenza vaccines.

    CSL’s operational business segments include CSL Behring and Seqirus. The company operates predominantly in Australia, the United States, Germany, the United Kingdom and Switzerland.

    CSL shares first began trading on the ASX in 1994 and today it ranks among the largest companies on the ASX 200. At the current share price, CSL pays a 1% dividend yield, unfranked. The company paid out both dividends for 2020.

    Why could CSL’s COVID vaccine prove to be better?

    Professor Paul Young is the head of the UQ program developing a COVID vaccine together with CSL.

    Addressing their vaccine, Young said (as quoted by the Australian Financial Review):

    It is a more traditional vaccine. I think it will be a far more robust vaccine . . . and a better option for the long term. So I still think it’s an important vaccine even though we’re a little bit behind the mRNA vaccines.

    Data from the group’s phase 1 trial is expected soon, with phase 2 and 3 trials scheduled to commence in December. Young said if the trials are successful, their vaccine could be ready for wider use in Australia by mid-2021.

    Young also highlighted the historic shortage of medicinal manufacturing capabilities in Australia:

    Our sovereign capacity is not perhaps what it could have been. Our technology has led into CSL’s technology just beautifully. That was an excellent marriage. But, many of the other vaccine types that could have been developed in Australia haven’t been able to progress because there hasn’t been the infrastructure to take them into the next stage of development.

    Although CSL is working on other projects and has numerous successes under its belt, the pending success or failure of its COVID vaccine is likely to have a significant impact on its share price.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post CSL (ASX:CSL) share price on watch after hints of ‘far more robust’ vaccine appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3mOZAMg

  • ASX stock of the day: Tilt (ASX:TLT) share price rockets 17% to new all-time high

    rise in asx tech share price represented by digitised rocket shooting out of person's hand

    The Tilt Renewables Ltd (ASX: TLT) share price is rocketing today, up 17.43% at the time of writing to $4.34 a share.

    Tilt shares closed at $3.74 on Friday afternoon last week, but opened at $4.25 this morning, before climbing all the way to $4.44 just after open (a new all-time high).

    At the current share price, Tilt shares are now up more than 33% year to date, and up more than 137% since the company’s ASX debut back in February 2018. They are also up 73.6% off Tilt’s 52-week low that we saw back in mid-March during the coronavirus-induced market crash.

    So what is Tilt Renewables? And why is the Tilt share price rocketing up today?

    Tilting towards clean energy

    Tilt Renewables is a renewable energy company (shocker) with a focus on the Australian and New Zealand energy markets. The company tells us its vision is “to be a leading developer and owner of renewable electricity generation in Australia and New Zealand. We tilt for a positive and sustainable future.”

    Even though it describes itself as a ‘renewable energy company’, Tilt is in the business of wind power at the present time. It currently owns and operates 8 wind farms across Australia and New Zealand.

    These include the Tararua Wind Farm in Manawatu, NZ; the Snowtown Windfarm in South Australia, the Crookwell Wind Farm in Goulburn, New South Wales, and the Salt Creek Wind Farm near Woorndoo, Victoria. The company also has another 22 new farms or upgrades in the pipeline, including the Dundonnell Wind Farm near Mortlake, Vic, and the Liverpool Range Windfarm just outside of Sydney.

    However, Tilt is also planning to expand into solar power as well. It currently has 2 solar farm projects in development – the Dysart Solar Farm near Mackay, Queensland, and the Illabo Solar Farm near Wagga Wagga, NSW.

    Tilt has had a good year so far, if the numbers are anything to go by. Back in October, Tilt reported that the 6 months ending 30 September 2020 saw profits after tax up 125% to compared to the prior corresponding period to $26.8 million. The company also saw basic earnings per share surge by 151% to 6.32 cents.

    Interestingly, more than half of this company’s outstanding shares are owned by 2 large corporate shareholders, Infratil Ltd (ASX: IFT) and Mercury NZ Ltd (ASX: MCY). And that takes us to why the share price is rocketing today.

    Why the Tilt Renewables share price is on fire today

    The Tilt share price performance today is almost certainly due to a release the company made to the markets this morning before open. In this release, Tilt informed the market that Infratil (Tilt’s largest shareholder with a 65.5% stake) has “commenced a strategic review of its shareholding” of Tilt.

    The company stated the following on this situation:

    TLT [Tilt Renewables] understands the IFT [Infratil] strategic review process may result in an offer from a third party for all outstanding shares in TLT and therefore the directors of TLT will begin preparations to be able to respond to such an offer. At this stage, the directors recommend TLT shareholders take no action.

    Infratil elaborated on this announcement by stating:

    Infratil has recently received a number of enquiries in relation to its Tilt shareholding. Given strong demand for high quality renewables platforms globally, Infratil considers it is prudent to assess alternatives for its Tilt shareholding, including divestment of its position.

    It’s likely that it’s for this reason that Tilt shares are rocketing today.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post ASX stock of the day: Tilt (ASX:TLT) share price rockets 17% to new all-time high appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/33RRryW

  • 2 of the best ASX tech shares you can buy today

    rise in asx tech share price represented by digitised rocket shooting out of person's hand

    One area of the market which has performed very strongly in recent years, and has been tipped to continue doing so in the future, is the tech sector.

    In light of this, it is no surprise that tech shares are among the most popular shares on the local share market.

    With that in mind, I have picked out two shares in the sector that come highly rated right now. They are as follows:

    Altium Limited (ASX: ALU)

    Altium is a leading printed circuit board (PCB) design software provider. It is best known for its industry-leading Altium Designer and cloud-based Altium 365 platforms but also has a number of other growing businesses. These include the Octopart search engine for electronic parts and the Nexus team-based PCB workflow solution.

    Due to the proliferation of electronic devices because of the rapidly growing Internet of Things and artificial intelligence markets, management is aiming to more than double its revenue between now and 2025/26. It is also believes that when it gets to 100,000 subscribers, double its current subscriber base, it will be in a position to dominate the industry.

    These plans appear to have gone down well with analysts at Morgan Stanley. They have an overweight rating and $40.00 price target on the company’s shares.

    Xero Limited (ASX: XRO)

    Xero is one of the world’s leading cloud-based business and accounting software platform providers. Over the last few years the company has evolved from being a place to do your accounts, to a full-service small business solution.

    This has helped underpin significant subscriber and recurring revenue growth. For example, during the first half of FY 2021, Xero finished the period with 2.45 million subscribers. This led to it reporting a 21% increase in operating revenue to NZ$409.8 million and a 15% lift in annualised monthly recurring revenue (AMRR) to NZ$877.6 million.

    One broker that is confident there will be more of the same in the future is Goldman Sachs. This morning it initiated coverage on the company with a buy rating and $157.00 price target. Goldman believes Xero can achieve a 2030 subscriber footprint of 7.4 million and generate NZ$3.4 billion in annual revenue.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Altium. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Xero. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post 2 of the best ASX tech shares you can buy today appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3ghcNuN

  • Kogan (ASX:KGN) busted for lying, fined six figures

    asx share penalty represented by lots of fingers pointing at disgraced businessman

    Kogan.com Ltd (ASX: KGN) has been ordered to pay a $350,000 fine for making false or misleading representations about a sale.

    The Federal Court found the company’s subsidiary, Kogan Australia Pty Ltd, misled customers by jacking up the prices of 621 products immediately before a ‘tax time’ sale.

    The online retailer then ran a sales promotion offering customers the code ‘TAXTIME’ to use at checkout for a 10% discount.

    “Consumers who used the promotional code to purchase these products paid the same as, or more than, they would have paid before or after the promotion,” said Australian Competition and Consumer Commission chair, Rod Sims.

    “Consumers were not receiving a genuine 10% discount as promised, and this affected high-value products such as Apple MacBooks, cameras and Samsung Galaxy mobile handsets.”

    To rub further salt into the wound of customers who thought they had a bargain, Kogan then put the standard prices back down after the promotion.

    Despite the absence of genuine discounts, the retailer used phrases like “48 hours left!” and “Ends midnight tonight!” in emails to customers to create a sense of urgency.

    Kogan’s deceptions were “serious”

    Justice Jennifer Davies said Kogan’s misbehaviour “must be viewed as serious”.

    “Misrepresentations about discounts offered on products not only harm purchasers acquiring such products on the basis that they are getting a genuine discount but also may impact on consumer confidence in discount promotions when legitimately made – that is, when products are being offered for sale with a genuine discount on price.”

    The Kogan share price was up 3.62% at 3:21pm AEDT, to hit $18.01. This was largely due to its acquisition of New Zealand e-tailer, Mighty Ape.

    In a statement to the ASX, Kogan dismissed the significance of the court findings.

    “The profit derived by the company from the promotion was immaterial,” the company stated.

    “Kogan.com has a compliance program in place, which comprises protocols for the internal and external review of promotional statements and associated collateral.”

    Kogan’s offences occurred in June 2018, with the ACCC starting legal action May last year. The court found the case in the watchdog’s favour July this year, with the resulting penalty handed down this month.

    The court also ordered Kogan to pay ACCC’s costs.

    Sims said the penalty was a “strong signal” to all internet retailers.

    “They must not entice consumers to purchase products with a promise of discounts that are not genuine.”

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Apple. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Kogan.com ltd. The Motley Fool Australia has recommended Apple and Kogan.com ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Kogan (ASX:KGN) busted for lying, fined six figures appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3lTIZFE

  • Austal (ASX:ASB) share price falls on contract delivery

    common investors mistakes represented by man looking sheepish

    The Austal Limited (ASX: ASB) share price is falling today despite the company announcing delivery of a new littoral combat ship to the United States Navy. During morning trade, the Austal share price reached $3.00, but has since retreated. At the time of writing, its shares are trading lower at $2.90, down 0.3%.

    Let’s take a look at Austal’s market update today.

    New ship delivery

    Austal advised that it has delivered an independence-class littoral combat ship to the US Navy.

    The warship is the 13th of its kind to be built at Austal’s US shipyard. In a symbolic move, the vessel was named USS Mobile after the city of Mobile in Alabama where the shipyard is based.

    The new combat ship is a high-speed, shallow-draft surface combatant with an aluminium trimaran hull that provides class leading, multi-mission capability. The ship is designed to defeat growing littoral threats and provide access and dominance along coastal waters. In addition, the vessel has operational flexibility to execute surface warfare, mine warfare and anti-submarine warfare missions.

    Currently, Austal’s US shipyard has four other littoral combat ships at various stages of construction. Under the program, USS Savannah and USS Canberra are being assembled. USS Santa Barbara and USS Augusta are under construction in the module manufacturing facility.

    In addition, construction of USS Kingsville and USS Pierre has yet to start but both have been signed off by the US Navy. Another 14 expeditionary fast transport vessels are also under contract, with 12 vessels already delivered. The remaining two ships include one that is being built and the other scheduled for future construction.

    What did management say?

    Austal CEO David Singleton welcomed the achievement, saying:

    What better way to end this challenging year than with the delivery of the future USS Mobile in its namesake city. This ship is a fantastic tribute to the spirit and determination of the people of Austal USA and the City of Mobile.

    Our warmest congratulations to the US Navy on the delivery of their latest independence-class littoral combat ship; another great symbol of the success of the United States defence industrial base and a highly capable addition to the fleet.

    About the Austal share price

    The Austal share price is heading towards recovery from a rolling 6 months. After reaching highs of $3.68 in June, the company’s shares are trading almost 22% lower today.

    Austal has a market capitalisation of $1.04 billion and a price-to-earnings (P/E) ratio of 11.7.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Austal Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Austal (ASX:ASB) share price falls on contract delivery appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3gpILoD

  • The Openpay (ASX:OPY) share price is down 23% in 2 months: Time to buy?

    Scared young male investor holds hand to forehead and looks at phone in front of yellow background

    It has been a disappointing start to the week for the Openpay Group Ltd (ASX: OPY) share price.

    In afternoon trade, the buy now pay later provider’s shares are down 3.5% to $2.46.

    Why is the Openpay share price dropping lower?

    The Openpay share price has been on a very poor run of late and is now down 23% since this time in October. This is despite the company’s performance remaining strong during this period.

    For example, in the middle of last month Openpay released a trading update for October and November to date.

    That update revealed that active plans were up 233% in October compared to the prior corresponding period and active customers were up 143%. This underpinned a 101% increase in total transaction value (TTV) to $25.8 million for the month.

    This positive form continued in November with Openpay achieving its strongest ever daily TTV of $915,000. This was thanks to Australian online sales initiatives including Click Frenzy and was an 11% increase on the company’s previous TTV record.

    Management believes this bodes well ahead of the peak sales season of Black Friday, Cyber Monday, and Christmas.

    That update also revealed that the company had signed major partnerships with US SaaS eCommerce group BigCommerce Holdings and online retailer Kogan.com Ltd (ASX: KGN).

    Since then, the company has held its annual general meeting and spoke positively about current trading and its future prospects.

    At the meeting, management commented: “To conclude, we have been extremely happy with our strategic delivery and strong operational performance, both in FY20 and in FY21 year to date. We have made significant progress in creating a great business and company, very much in line with our vision ‘to change the way people pay, for the better’ and with the pillars of our growth strategy.”

    Is this a buying opportunity?

    One broker that sees the recent Openpay share price weakness as a buying opportunity is Shaw & Partners.

    Last month its analysts responded to its trading update by reaffirming their (high risk) buy rating and $5.00 price target.

    They believe the company is well-placed for growth and note that its shares trade at a significant discount to the likes of Afterpay Ltd (ASX: APT) and Zip Co Ltd (ASX: Z1P).

    This Tiny ASX Stock Could Be the Next Afterpay

    One little-known Australian IPO has doubled in value since January, and renowned Australian Moonshot stock picker Anirban Mahanti sees a potential millionaire-maker in waiting…

    Because ‘Doc’ Mahanti believes this fast-growing company has all the hallmarks of genuine Moonshot potential, forget ‘buy now pay later’, this stock could be the next hot stock on the ASX.

    Doc and his team have published a detailed report on this tiny ASX stock. Find out how you can access what could be the NEXT Afterpay today!

    Returns as of 6th October 2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Kogan.com ltd and ZIPCOLTD FPO. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool Australia has recommended Kogan.com ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post The Openpay (ASX:OPY) share price is down 23% in 2 months: Time to buy? appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/39RRcYz

  • Will this $65 billion bonanza turbocharge the Elders (ASX:ELD) share price?

    farming asx share price rise represented by rejoicing farmer in field

    The Elders Ltd (ASX: ELD) share price is sliding today, down 2.33% in early afternoon trading.

    At $12.07, the Elders share price hit its 2020 peak on 20 October. At the time, Elders shares were up 87% for the year. Since then, shares have retraced around 17%. Still, that leaves the share price up an impressive 56% year to date.

    By comparison, the broader S&P/ASX 200 Index (ASX: XJO) is flat for the year.

    And the latest data from the Australian Bureau of Agricultural and Resource Economics and Sciences (ABARES) could see Elders continue to outperform into 2021.

    We’ll look at that below. But first…

    What does Elders do?

    Elders Ltd provides a range of services to customers working in the agricultural industry. These services include finance, banking and home loans, real estate, insurance and rural services.

    Founded in 1839, Elders has grown to become the country’s largest listed rural services provider and agribusiness. Elders shares first began trading on the Australian exchange in 1981.

    What did ABARES report that could boost the Elders share price?

    In its December quarter agriculture commodities report, ADARES forecast Australia’s farmgate value is likely to reach $65 billion in 2020/21. This comes following our second largest winter crop and with seasonal rainfall predicted to be promising.

    Commenting on the findings, ABARES executive director Steve Hatfield-Dodds stated:

    We’re expecting a near all-time high winter crop, the best ever in New South Wales, and a more favourable outlook for summer cropping than we have seen in recent years. Livestock prices have also stayed high with herd and flock rebuilding, and continued international demand.

    While ABARES predicts that farm production will increase 7%, to $65 billion, it expects export values to fall by 7%, down to $44.7 billion.

    Part of the export drop is attributed to the lingering effect of past dry seasons. But Hatfield-Dodds also points to trade uncertainties, particularly with China, as likely to drag on agricultural exports, saying, “There are a number of risks present for the rest of 2021 that remain a watch point, including wine trade with China and labour shortages for the horticulture sector.”

    Trade and labour issues will remain a wild card moving into 2021. But with a bumper winter crop and potentially strong summer crop, it will be interesting to see how the Elders share price performs moving forward.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Elders Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Will this $65 billion bonanza turbocharge the Elders (ASX:ELD) share price? appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/36QjrVu

  • Leading brokers name 3 ASX shares to buy today

    finger pressing red button on keyboard labelled Buy

    With so many shares to choose from on the ASX, it can be hard to decide which ones to buy.

    The good news is that brokers across the country are doing a lot of the hard work for you.

    Three top shares that leading brokers have named as buys this week are listed below. Here’s why they are bullish on them:

    Afterpay Ltd (ASX: APT)

    According to a note out of Credit Suisse, its analysts have initiated coverage on this payments company’s shares with an outperform rating and $124.00 price target. Credit Suisse believes Afterpay is well-positioned for growth and has the potential to grow its underlying sales materially over the next five years. This is thanks to the structural shift to online shopping, a decline in credit card use, and its exposure to younger demographics. The latter are expected to increase their spending in the coming years. The Afterpay share price is changing hands for $96.02 this afternoon.

    Fortescue Metals Group Limited (ASX: FMG)

    A note out of Macquarie reveals that its analysts have retained their outperform rating and lifted their price target on this iron ore producer’s shares to $23.00. The broker made the move in response to a significant rise in iron ore prices, which it believes will result in sizeable free cash flow yields. The broker has also lifted its earnings and dividend expectations for the next couple of years. The Fortescue share price is fetching $21.34 on Monday.

    Qantas Airways Limited (ASX: QAN)

    Analysts at UBS have retained their buy rating and increased their price target on this airline operator’s shares to $6.20. According to the note, the broker believes that Qantas’ balance sheet risk has significantly reduced recently. This is thanks to COVID vaccine developments, border re-openings, and its plan to increase capacity to 70% of pre-COVID levels. It also notes that Qantas appears to be winning market share domestically. The Qantas share price is trading at $5.46 this afternoon.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Leading brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3lJLquo